Choosing between aspirin or P2Y12 monotherapy after short course of DAPT

Am Heart J. 2020 Dec:230:100. doi: 10.1016/j.ahj.2020.09.003.

Authors

Toshiki Kuno¹, Hiroki Ueyama², Hisato Takagi³, Sripal Bangalore⁴

Affiliations

¹ Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY. Electronic address: Toshiki.Kuno@mountsinai.org.
² Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY.
³ Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.
⁴ Division of Cardiovascular Medicine, New York University Grossman School of Medicine, New York, NY.

PMID: 33248474
DOI: 10.1016/j.ahj.2020.09.003

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin
Humans
Network Meta-Analysis
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors*
Purinergic P2Y Receptor Antagonists
Randomized Controlled Trials as Topic

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Aspirin